Paper9815919
Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
Debinski W and 4 others. Clin Cancer Res, 1995. Cited by 208 papers, by iCite.
Cite this record
ConductScience Library. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Papers, record 9815919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9815919
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ADP Ribose Transferases | Major topic |
| Bacterial Toxins | Major topic |
| Brain Neoplasms | Major topic |
| Exotoxins | Major topic |
| Glioma | Major topic |
| Immunotoxins | Major topic |
| Interleukin-13 | Major topic |
| Neoplasm Proteins | Major topic |
| Receptors, Interleukin | Major topic |
| Virulence Factors | Major topic |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Interleukin-13 Receptor alpha1 Subunit | |
| Interleukin-4 | |
| Receptors, Interleukin-13 | |
| Tumor Cells, Cultured | |
| Pseudomonas aeruginosa Exotoxin A |
Source PubMed
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 208 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794993 | Payload-Free Epitope Imprinted Polymer Nanoparticles Selectively Targeting IL-13Rα2 and Inhibition of Diffuse Midline Glioma Cells. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794993 | PubMed |
| 42353280 | Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353280 | PubMed |
| 42057694 | Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42057694 | PubMed |
| 41540212 | Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma. | Commun Biol | 2026 | https://conductscience.org/library/papers/41540212 | PubMed |
| 40663259 | Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling. | Clin Exp Metastasis | 2025 | https://conductscience.org/library/papers/40663259 | PubMed |
| 39204078 | A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39204078 | PubMed |
| 38486856 | Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/38486856 | PubMed |
| 38261143 | Adjuvant convection-enhanced delivery for the treatment of brain tumors. | J Neurooncol | 2024 | https://conductscience.org/library/papers/38261143 | PubMed |
| 38201655 | Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38201655 | PubMed |
| 37443804 | Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future. | Cells | 2023 | https://conductscience.org/library/papers/37443804 | PubMed |
| 37443750 | Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas. | Cells | 2023 | https://conductscience.org/library/papers/37443750 | PubMed |
| 36830725 | Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide. | Biomolecules | 2023 | https://conductscience.org/library/papers/36830725 | PubMed |
| 36744399 | H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. | Expert Opin Ther Targets | 2023 | https://conductscience.org/library/papers/36744399 | PubMed |
| 36303101 | Clinical and Translational Advances in Glioma Immunotherapy. | Neurotherapeutics | 2022 | https://conductscience.org/library/papers/36303101 | PubMed |
| 35832263 | Convection-Enhanced Arborizing Catheter System Improves Local/Regional Delivery of Infusates Versus a Single-Port Catheter in Ex Vivo Porcine Brain Tissue. | J Eng Sci Med Diagn Ther | 2021 | https://conductscience.org/library/papers/35832263 | PubMed |
| 35681612 | Dialogue among Lymphocytes and Microglia in Glioblastoma Microenvironment. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681612 | PubMed |
| 35464460 | Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35464460 | PubMed |
| 35386310 | Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35386310 | PubMed |
| 34976821 | Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin. | Front Oncol | 2021 | https://conductscience.org/library/papers/34976821 | PubMed |
| 34884607 | Genetically Modified Cellular Therapies for Malignant Gliomas. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884607 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9815919
GET https://conductscience.org/api/papers/v1/9815919/cited_by?page=2